KDM6A and neoplasm: In contrast, KDM5C and KDM6A have been shown to exhibit tumor-suppressive effects (e.g., metabolic repression and inhibition of cell proliferation) in intrahepatic cholangiocarcinoma [24] and hepatocellular carcinoma [16], respectively.